The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN).
The investment seeks to track the performance of the MSCI US Investable Market Index (IMI)/Health Care 25/50.
The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index (IMI)/Health Care 25/50, an index made up of stocks of large, mid-size, and small U.S. companies within the health care sector, as classified under the GICS. The Advisor attempts to replicate the target index by seeking to invest all, or substantially all, of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. The fund is non-diversified.
The average market capitalization across the Vanguard Health Care Index Admiral MF is 248.31B. The market cap for tickers in the group ranges from 141.43B to 561.54B. LLY holds the highest valuation in this group at 561.54B. The lowest valued company is AMGN at 141.43B.
The average weekly volume growth across all stocks in the Vanguard Health Care Index Admiral MF was 359%. For the same stocks of the MF, the average monthly volume growth was 110% and the average quarterly volume growth was 116%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 33
P/E Growth Rating: 38
Price Growth Rating: 48
SMR Rating: 45
Profit Risk Rating: 34
Seasonality Score: 3 (-100 ... +100)